LifeStance Health Group, Inc.
NASDAQ:LFST
6.86 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 312.331 | 300.437 | 280.603 | 262.895 | 259.578 | 252.589 | 229.36 | 217.56 | 209.527 | 203.095 | 189.995 | 173.835 | 160.549 | 143.132 | 118.121 | 101.982 | 45.453 | 73.106 |
| Cost of Revenue
| 233.125 | 228.275 | 219.506 | 186.686 | 186.607 | 182.987 | 166.668 | 157.267 | 149.697 | 148.893 | 135.745 | 121.783 | 109.341 | 99.134 | 79.142 | 68.847 | 31.275 | 51.634 |
| Gross Profit
| 79.206 | 72.162 | 61.097 | 76.209 | 72.971 | 69.602 | 62.692 | 60.293 | 59.83 | 54.202 | 54.25 | 52.052 | 51.208 | 43.998 | 38.979 | 33.135 | 14.178 | 21.472 |
| Gross Profit Ratio
| 0.254 | 0.24 | 0.218 | 0.29 | 0.281 | 0.276 | 0.273 | 0.277 | 0.286 | 0.267 | 0.286 | 0.299 | 0.319 | 0.307 | 0.33 | 0.325 | 0.312 | 0.294 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 95.153 | 88.934 | 93.368 | 130.945 | 101.854 | 84.626 | 89.817 | 81.248 | 103.559 | 103.369 | 152.652 | 162.943 | 85.479 | 32.651 | 23.665 | 19.534 | 8.642 | 13.662 |
| Selling & Marketing Expenses
| -0.381 | -0.095 | -0.983 | 0 | 0 | 0 | 8.632 | 0 | 0 | 0 | 1.942 | 0 | 0 | 0 | 2.605 | 0 | 0 | 0 |
| SG&A
| 94.772 | 88.839 | 92.385 | 130.945 | 101.854 | 84.626 | 89.817 | 81.248 | 103.559 | 103.369 | 152.652 | 162.943 | 85.479 | 32.651 | 23.665 | 19.534 | 8.642 | 13.662 |
| Other Expenses
| -0.004 | -0.074 | -0.042 | -0.001 | -0.024 | 19.069 | 18.887 | 17.884 | 16.743 | 15.684 | 15.357 | 13.777 | 12.774 | 12.228 | -0.197 | 10.91 | 5.432 | 2.175 |
| Operating Expenses
| 94.772 | 88.839 | 92.385 | 150.566 | 121.384 | 103.695 | 108.704 | 99.132 | 120.302 | 119.053 | 168.009 | 176.72 | 98.253 | 44.879 | 35.033 | 30.444 | 14.074 | 15.837 |
| Operating Income
| -15.566 | -16.677 | -31.288 | -74.357 | -48.413 | -34.093 | -46.012 | -38.839 | -60.472 | -64.851 | -115.036 | -124.668 | -47.045 | -0.881 | 3.946 | 2.691 | 0.104 | 5.635 |
| Operating Income Ratio
| -0.05 | -0.056 | -0.112 | -0.283 | -0.187 | -0.135 | -0.201 | -0.179 | -0.289 | -0.319 | -0.605 | -0.717 | -0.293 | -0.006 | 0.033 | 0.026 | 0.002 | 0.077 |
| Total Other Income Expenses Net
| -7.055 | -4.057 | -7.028 | 1.866 | 1.512 | -4.186 | -7.704 | -3.367 | -7.332 | -4.153 | -3.602 | -1.032 | -3.602 | -1.93 | -3.884 | -0.638 | -0.254 | -0.599 |
| Income Before Tax
| -22.621 | -20.734 | -38.316 | -77.968 | -52.02 | -38.279 | -53.716 | -42.206 | -67.804 | -69.004 | -118.638 | -129.203 | -73.821 | -11.443 | -7.067 | -4.368 | -5.712 | 3.356 |
| Income Before Tax Ratio
| -0.072 | -0.069 | -0.137 | -0.297 | -0.2 | -0.152 | -0.234 | -0.194 | -0.324 | -0.34 | -0.624 | -0.743 | -0.46 | -0.08 | -0.06 | -0.043 | -0.126 | 0.046 |
| Income Tax Expense
| 0.656 | 0.363 | 6.643 | -16.385 | -6.542 | -4.037 | -7.06 | -4.353 | 0.923 | -6.676 | -10.608 | -8.751 | -3.788 | -2.761 | -1.578 | -1.074 | -1.37 | 0.703 |
| Net Income
| -23.277 | -21.097 | -44.959 | -61.583 | -45.478 | -34.242 | -46.656 | -37.853 | -68.727 | -62.328 | -108.03 | -120.452 | -70.033 | -8.682 | -5.489 | -3.294 | -4.342 | 2.208 |
| Net Income Ratio
| -0.075 | -0.07 | -0.16 | -0.234 | -0.175 | -0.136 | -0.203 | -0.174 | -0.328 | -0.307 | -0.569 | -0.693 | -0.436 | -0.061 | -0.046 | -0.032 | -0.096 | 0.03 |
| EPS
| -0.061 | -0.056 | -0.12 | -0.17 | -0.13 | -0.095 | -0.12 | -0.11 | -0.19 | -0.18 | -0.33 | -0.35 | -0.22 | -0.023 | -0.018 | -0.009 | -0.012 | 0.006 |
| EPS Diluted
| -0.061 | -0.056 | -0.12 | -0.17 | -0.13 | -0.095 | -0.12 | -0.11 | -0.19 | -0.18 | -0.33 | -0.35 | -0.22 | -0.023 | -0.018 | -0.009 | -0.012 | 0.006 |
| EBITDA
| 3.034 | 5.887 | -9.071 | -54.737 | -28.907 | -15.069 | -27.199 | -21.099 | -43.729 | -49.167 | -99.679 | -111.923 | -37.873 | 9.417 | 15.117 | 12.963 | 5.282 | 7.211 |
| EBITDA Ratio
| 0.01 | 0.02 | -0.032 | -0.208 | -0.111 | -0.06 | -0.119 | -0.097 | -0.209 | -0.242 | -0.525 | -0.644 | -0.236 | 0.066 | 0.128 | 0.127 | 0.116 | 0.099 |